Literature DB >> 19748889

Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide.

Scott B Widenmaier1, Ziliang Ao, Su-Jin Kim, Garth Warnock, Christopher H S McIntosh.   

Abstract

Glucose-dependent insulinotropic polypeptide (GIP) potentiates glucose-stimulated insulin secretion, insulin biosynthesis, and beta-cell proliferation and survival. In previous studies GIP was shown to promote beta-cell survival by modulating the activity of multiple signaling modules and regulating gene transcription of pro- and anti-apoptotic bcl-2 family proteins. We have now evaluated the mechanisms by which GIP regulates the dynamic interactions between cytoplasmic bcl-2 family members and the mitochondria in INS-1 cells during apoptosis induced by treatment with staurosporine (STS), an activator of the mitochondria-mediated apoptotic pathway. STS induced translocation of bad and bimEL, activation of mitochondrial bax, release of mitochondrial cytochrome c, cleavage of caspase-3, and apoptosis. Each response was significantly diminished by GIP. Using selective enzyme inhibitors, overexpression of dominant-negative Akt, and Akt siRNA, it was demonstrated that GIP promoted beta-cell survival via Akt-dependent suppression of p38 MAPK and JNK and that combined inhibition was sufficient to explain the entire pro-survival responses to GIP during STS treatment. This signaling pathway also explained the pro-survival effects of GIP on INS-1 cells exposed to two other promoters of stress: thapsigargin (endoplasmic reticulum stress) and etoposide (genotoxic stress). Importantly, we discovered that GIP suppressed p38 MAPK and JNK via Akt-mediated changes in the phosphorylation state of the apoptosis signal-regulating kinase 1 in INS-1 cells and human islets, resulting in inhibition of its activity. Inhibition of apoptosis by GIP is therefore mediated via a key pathway involving Akt-dependent inhibition of apoptosis signal-regulating kinase 1, which subsequently prevents the pro-apoptotic actions of p38 MAPK and JNK.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748889      PMCID: PMC2781592          DOI: 10.1074/jbc.M109.060178

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion.

Authors:  J A Ehses; S S Lee; R A Pederson; C H McIntosh
Journal:  J Biol Chem       Date:  2001-04-25       Impact factor: 5.157

2.  Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1.

Authors:  A H Kim; G Khursigara; X Sun; T F Franke; M V Chao
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion.

Authors:  Y Kashima; T Miki; T Shibasaki; N Ozaki; M Miyazaki; H Yano; S Seino
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

4.  Apoptosis in cultured rat islets of langerhans and occurrence of Bcl-2, Bak, Bax, Fas and Fas ligand.

Authors:  J Hanke
Journal:  Cells Tissues Organs       Date:  2001       Impact factor: 2.481

5.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis.

Authors:  K Tobiume; A Matsuzawa; T Takahashi; H Nishitoh; K Morita ; K Takeda; O Minowa; K Miyazono; T Noda; H Ichijo
Journal:  EMBO Rep       Date:  2001-03       Impact factor: 8.807

6.  Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia.

Authors:  D Ross Laybutt; Hideaki Kaneto; Wendy Hasenkamp; Shane Grey; Jean-Christophe Jonas; Dennis C Sgroi; Adam Groff; Christiane Ferran; Susan Bonner-Weir; Arun Sharma; Gordon C Weir
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

7.  Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling.

Authors:  A Trümper; K Trümper; H Trusheim; R Arnold; B Göke; D Hörsch
Journal:  Mol Endocrinol       Date:  2001-09

Review 8.  Mechanisms of caspase activation and inhibition during apoptosis.

Authors:  Yigong Shi
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

9.  Nicotine inactivation of the proapoptotic function of Bax through phosphorylation.

Authors:  Meiguo Xin; Xingming Deng
Journal:  J Biol Chem       Date:  2005-01-10       Impact factor: 5.157

10.  Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells.

Authors:  A Trümper; K Trümper; D Hörsch
Journal:  J Endocrinol       Date:  2002-08       Impact factor: 4.286

View more
  42 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.

Authors:  Annalisa Natalicchio; Rossella Labarbuta; Federica Tortosa; Giuseppina Biondi; Nicola Marrano; Alessandro Peschechera; Emanuele Carchia; Maura Roberta Orlando; Anna Leonardini; Angelo Cignarelli; Piero Marchetti; Sebastio Perrini; Luigi Laviola; Francesco Giorgino
Journal:  Diabetologia       Date:  2013-08-31       Impact factor: 10.122

3.  Pancreatic β-cell prosurvival effects of the incretin hormones involve post-translational modification of Kv2.1 delayed rectifier channels.

Authors:  S-J Kim; S B Widenmaier; W S Choi; C Nian; Z Ao; G Warnock; C H S McIntosh
Journal:  Cell Death Differ       Date:  2011-08-05       Impact factor: 15.828

4.  Resveratrol mobilizes Ca2+ from intracellular stores and induces c-Jun N-terminal kinase activation in tumoral AR42J cells.

Authors:  Lourdes Garcia-Sanchez; Patricia Santofimia-Castaño; Alvaro Miro-Moran; Jose A Tapia; Gines M Salido; Antonio Gonzalez
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

5.  Wnt5a and Wnt11 regulate mammalian anterior-posterior axis elongation.

Authors:  Philipp Andre; Hai Song; Wantae Kim; Andreas Kispert; Yingzi Yang
Journal:  Development       Date:  2015-03-26       Impact factor: 6.868

Review 6.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

7.  Induction of MKP-1 prevents the cytotoxic effects of PI3K inhibition in hilar cholangiocarcinoma cells.

Authors:  Kawin Leelawat; Wandee Udomchaiprasertkul; Siriluck Narong; Surang Leelawat
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-10       Impact factor: 4.553

8.  PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma.

Authors:  Ridwan Alam; Chad R Schultz; William A Golembieski; Laila M Poisson; Sandra A Rempel
Journal:  Neuro Oncol       Date:  2013-02-03       Impact factor: 12.300

9.  A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control.

Authors:  Scott B Widenmaier; Su-Jin Kim; Gary K Yang; Thomas De Los Reyes; Cuilan Nian; Ali Asadi; Yutaka Seino; Timothy J Kieffer; Yin Nam Kwok; Christopher H S McIntosh
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

10.  Glucose-Dependent Insulinotropic Peptide Prevents Serum Deprivation-Induced Apoptosis in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.

Authors:  J L Berlier; I Kharroubi; J Zhang; A Dalla Valle; S Rigutto; M Mathieu; V Gangji; J Rasschaert
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.